Source:http://linkedlifedata.com/resource/pubmed/id/10816741
Switch to
| Predicate | Object |
|---|---|
| rdf:type | |
| lifeskim:mentions | |
| pubmed:issue |
4
|
| pubmed:dateCreated |
2000-6-7
|
| pubmed:language |
fre
|
| pubmed:journal | |
| pubmed:citationSubset |
IM
|
| pubmed:chemical | |
| pubmed:status |
MEDLINE
|
| pubmed:issn |
0025-682X
|
| pubmed:author | |
| pubmed:issnType |
Print
|
| pubmed:volume |
59
|
| pubmed:owner |
NLM
|
| pubmed:authorsComplete |
Y
|
| pubmed:pagination |
331-2
|
| pubmed:dateRevised |
2004-11-17
|
| pubmed:meshHeading |
pubmed-meshheading:10816741-Animals,
pubmed-meshheading:10816741-Humans,
pubmed-meshheading:10816741-Melarsoprol,
pubmed-meshheading:10816741-Metabolic Clearance Rate,
pubmed-meshheading:10816741-Patient Selection,
pubmed-meshheading:10816741-Treatment Outcome,
pubmed-meshheading:10816741-Trypanocidal Agents,
pubmed-meshheading:10816741-Trypanosoma brucei gambiense,
pubmed-meshheading:10816741-Trypanosoma brucei rhodesiense,
pubmed-meshheading:10816741-Trypanosomiasis, African
|
| pubmed:year |
1999
|
| pubmed:articleTitle |
[Melarsoprol].
|
| pubmed:publicationType |
Journal Article
|